Part 1. Basic concepts
Chapter 1. Issues in Translation of Pharmacogenomics into Clinical Practice.
Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu
Chapter 2. Molecular Diagnostic Methods in Pharmacogenomics Nikolina Babic*, Loren J. Joseph, Kiang-Teck J. Yeo
Chapter 3. Economics of pharmacogenomic testing in clinical practice
Alan H.B. Wu
Chapter 4. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System
Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.
Part 2. Specific pharmacogenomic targets: Chemotherapeutics
Chapter 5. Irinotecan
R. Stephanie Huang, Federico Innocenti and Mark J. Ratain
Chapter 6. Pharmacogenomics of tamoxifen
Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman
Chapter 7. Thiopurines
Terreia S. Jones, Mary V. Relling
Part 3. Specific pharmacogenomic targets: Cardiovascular drugs
Chapter 8. The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs
Charles Eby
Chapter 9. Clopidogrel and Salicylates
Janice Y Chyou, Marc S Sabatine
Chapter 10. DNA-Guided Statin Therapy
Gualberto Ruaño, Richard L. Seip, Jorge Duconge
Chapter 11. The statin response gene: Kif6
....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.
Part 4. Drugs that cause delayed hypersensitivity
Chapter 12. Abacavir
Elizabeth J. Phillips, Simon A. Mallal
Chapter 13. Allopurinol
Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen
Chapter 14. Carbamazepine and its structurally-related antiepiletics
Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen
Part 5........ Miscellaneous drugs
Chapter 15. Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury
Hong-Kee Lee, Lionel D. Lewis
Chapter 16. Immunosuppressants Pharmacogenomics
Ping Wang